Steven Cohen’s Tonix Pharmaceuticals TNXP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$10.9M Sell
1,116,449
-50,303
-4% -$594K 0.01% 1306
2026
Q2
$14.9M Buy
1,166,752
+1,041,338
+830% +$13.4M 0.02% 1044
2026
Q1
$1.72M Sell
125,414
-494,619
-80% -$7.61M ﹤0.01% 2419
2025
Q4
$9.7M Buy
+620,033
New +$11.4M 0.01% 1376
2025
Q1
– Sell
-15,963
Closed -$526K – 2538
2024
Q4
$526K Buy
+15,963
New +$332K ﹤0.01% 1653

Other funds holding TNXP

Steven Cohen's TNXP Position: Q3 2026 in Review

Steven Cohen reduced its Tonix Pharmaceuticals (TNXP) stake by 4.3% in Q3 2026, selling an estimated $594K and leaving 1,116,449 shares worth $10.9M. The position accounts for 0.01% of the portfolio, ranked #1306.

Steven Cohen first reported a position in TNXP in Q4 2024 and has held it in 5 quarters since. The position peaked at $14.9M in Q2 2026. 113 funds tracked by Wall St. Rank hold TNXP as of Q3 2026.

  • Steven Cohen held 1,116,449 shares of Tonix Pharmaceuticals worth $10.9M as of Q3 2026.
  • Steven Cohen sold 50,303 Tonix Pharmaceuticals shares in Q3 2026, an estimated $594K.
  • Tonix Pharmaceuticals made up 0.01% of Steven Cohen's portfolio in Q3 2026, its #1306 holding.
  • Steven Cohen first reported a position in Tonix Pharmaceuticals in Q4 2024 and has held it in 5 quarters since.
  • Steven Cohen's Tonix Pharmaceuticals position peaked at $14.9M in Q2 2026.
  • 113 funds tracked by Wall St. Rank held Tonix Pharmaceuticals as of Q3 2026.

Based on Point72 Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.